secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioPlus Acquisition Corp. (—)
CIK:        0001856653
Form:       8-K
Filed at:   2023-06-08T23:59:59+00:00
Accession:  0001193125-23-163519
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 2.03, 3.02, 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioPlus shareholders approve extension to Dec 7, 2023; 9.9M shares redeemed for $104.7M
--------------------------------------------------------------------------------

- Shareholders approved extension of business combination deadline from June 7, 2023 to December 7, 2023.
- 9,942,523 Class A shares redeemed at ~$10.53/share, aggregate ~$104.7M; trust balance reduced to ~$137.5M.
- Sponsor issued up to $1.5M promissory note to fund monthly trust deposits of $250,000 for extension.
- Sponsor converted 5,749,999 Class B shares into Class A shares; all other proposals passed overwhelmingly.
- Auditor ratification passed; WithumSmith+Brown retained for FY 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1856653/000119312523163519/0001193125-23-163519-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1856653/000119312523163519/d499807d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-163519

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer